SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Wisee who wrote (559)5/7/1998 3:42:00 PM
From: F. Jay Abella, III  Respond to of 1185
 
Are these real dollars or biotech dollars?

Did they get anything up front?

FJA



To: Wisee who wrote (559)5/7/1998 3:45:00 PM
From: Wisee  Respond to of 1185
 
I don't think the Forbes Medi-Tech licensing deal with Novartis even comes close to amount that Nortran just announced with Hoffman LaRoche.

Geez, and I thought today would be a boring day..

Wisee



To: Wisee who wrote (559)5/7/1998 3:48:00 PM
From: Paul S.  Read Replies (2) | Respond to of 1185
 
Wisee, I have heard the same rumor, but I was told that a group in the states is taking a run at nortran with a possible $10.00per share buyout. Who knows if this is fiction or not but, initial speculation on the licensing deal was correct. Maybe this is true also.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News